49 related articles for article (PubMed ID: 27556844)
1. Patterns and predictors of referral to the specialized chronic lymphocytic leukemia clinic in Manitoba, Canada.
Righolt CH; Zhang G; Gibson SB; Johnston JB; Banerji V; Mahmud SM
Cancer Epidemiol; 2022 Dec; 81():102279. PubMed ID: 36279643
[TBL] [Abstract][Full Text] [Related]
2. Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry.
Mato AR; Ghosh N; Sharman JP; Brander D; Gutierrez M; Huang Q; Wu LH; Young A; Upasani S; Naganuma M; Barrientos JC
Blood Adv; 2023 Sep; 7(17):4760-4764. PubMed ID: 36206191
[No Abstract] [Full Text] [Related]
3. Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
Mato AR; Nabhan C; Barr PM; Ujjani CS; Hill BT; Lamanna N; Skarbnik AP; Howlett C; Pu JJ; Sehgal AR; Strelec LE; Vandegrift A; Fitzpatrick DM; Zent CS; Feldman T; Goy A; Claxton DF; Bachow SH; Kaur G; Svoboda J; Nasta SD; Porter D; Landsburg DJ; Schuster SJ; Cheson BD; Kiselev P; Evens AM
Blood; 2016 Nov; 128(18):2199-2205. PubMed ID: 27601462
[TBL] [Abstract][Full Text] [Related]
4. Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia.
Herishanu Y; Polliack A; Shenhar-Tsarfaty S; Weinberger R; Gelman R; Ziv-Baran T; Zeltser D; Shapira I; Berliner S; Rogowski O
Ann Med; 2017 Feb; 49(1):75-82. PubMed ID: 27595291
[TBL] [Abstract][Full Text] [Related]
5. Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group.
Kovacs G; Robrecht S; Fink AM; Bahlo J; Cramer P; von Tresckow J; Maurer C; Langerbeins P; Fingerle-Rowson G; Ritgen M; Kneba M; Döhner H; Stilgenbauer S; Klapper W; Wendtner CM; Fischer K; Hallek M; Eichhorst B; Böttcher S
J Clin Oncol; 2016 Nov; 34(31):3758-3765. PubMed ID: 27573660
[TBL] [Abstract][Full Text] [Related]
6. Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia.
Strati P; Chaffee KG; Achenbach SJ; Slager SL; Leung N; Call TG; Ding W; Parikh SA; Kay NE; Shanafelt TD
Haematologica; 2017 Jan; 102(1):e22-e25. PubMed ID: 27634202
[No Abstract] [Full Text] [Related]
7. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study.
Thompson PA; Lévy V; Tam CS; Al Nawakil C; Goudot FX; Quinquenel A; Ysebaert L; Michallet AS; Dilhuydy MS; Van Den Neste E; Dupuis J; Keating MJ; Meune C; Cymbalista F
Br J Haematol; 2016 Nov; 175(3):462-466. PubMed ID: 27611233
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders.
Mulligan SP; Ward CM; Whalley D; Hilmer SN
Br J Haematol; 2016 Nov; 175(3):359-364. PubMed ID: 27611114
[No Abstract] [Full Text] [Related]
10. Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.
Sánchez-Ramón S; Dhalla F; Chapel H
Front Immunol; 2016; 7():317. PubMed ID: 27597852
[TBL] [Abstract][Full Text] [Related]
11. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
[TBL] [Abstract][Full Text] [Related]
12. Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Monoclonal B-Cell Lymphocytosis.
Hasserjian RP
Surg Pathol Clin; 2010 Dec; 3(4):907-31. PubMed ID: 26839294
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects of monoclonal B-cell lymphocytosis.
Mowery YM; Lanasa MC
Cancer Control; 2012 Jan; 19(1):8-17. PubMed ID: 22143058
[TBL] [Abstract][Full Text] [Related]
14. Differentiating Chronic Lymphocytic Leukemia from Small Lymphocytic Lymphoma: A Manitoba Cancer Registry Perspective.
Deneka A
J Registry Manag; 2016; 43(2):90-1. PubMed ID: 27556844
[TBL] [Abstract][Full Text] [Related]
15. High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort.
Seftel MD; Demers AA; Banerji V; Gibson SB; Morales C; Musto G; Pitz MW; Johnston JB
Leuk Res; 2009 Nov; 33(11):1463-8. PubMed ID: 19581000
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcome of patients with CLL who are referred or nonreferred to a specialized CLL clinic: a Canadian population-based study.
Beiggi S; Banerji V; Deneka A; Griffith J; Gibson SB; Johnston JB
Cancer Med; 2016 Jun; 5(6):971-9. PubMed ID: 26889755
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
